BRLS · XBRL financial data

Borealis Foods financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BRLS's year ends in late December)

In thousands of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Revenue	6,447	7,725	7,458*	7,895	5,325	7,688	6,760*	6,846	7,188	7,104	10,338*	7,782
Revenue from contracts with customers	6,827	8,265	7,507*	—	5,476	8,076	7,064*	—	—	—	—	—
Cost of revenue	—	—	—	7,653	4,903	6,415	—	5,946	6,673	6,063	—	—
Cost of goods and services sold	7,486	8,202	6,901*	7,653	4,903	6,415	6,509*	5,946	—	—	year only	6,529
Gross profit	(1,039)	(477)	—	243	422	1,273	—	900	515	1,041	—	839
Research and development	0	37	37*	37	50	56	55*	52	52	52	46*	50
Selling, general and administrative	5,409	3,946	5,071*	7,216	5,612	4,894	4,873*	3,817	3,871	2,965	3,894*	2,900
General and administrative	—	2,786	—	—	—	1,987	—	—	2,505	—	—	—
Operating income (loss)	(698)	(1,197)	(1,117)*	(6,973)	(5,189)	(3,621)	(4,622)*	(2,917)	(3,356)	(1,925)	(2,838)*	(2,061)
Interest income	—	—	year only	—	—	—	—	—	—	—	—	—
Interest expense	1,839	2,166	1,741*	1,459	1,099	1,208	1,294*	1,259	1,228	1,855	1,644*	1,450
Other income (expense)	—	4	—	(1,459)	(1,094)	(3)	(5,060)*	(1,270)	(1,230)	(1,856)	(3,653)*	(1,451)
Income tax expense (benefit)	15	0	0*	—	14	1	(150)*	—	14	0*	(81)*	—
Net income (loss)	(452)	(921)	(838)*	(8,432)	(6,298)	(4,832)	(5,766)*	(4,188)	(4,600)	(3,781)	(6,410)*	(3,512)
Earnings per share, basic USD per share	(0.77)	(0.61)	(2.56)	(0.49)	(0.29)	(0.23)	(1.25)	(0.20)	0.21	(0.18)	—	(0.16)
Earnings per share, diluted USD per share	(0.77)	(0.61)	(2.56)	(0.49)	(0.29)	(0.23)	(1.25)	(0.20)	0.21	(0.18)	—	(0.16)
Weighted average shares, basic thousands of shares	10,732	10,732	10,750	17,080	21,379	21,379	20,310	21,379	21,407	21,463	21,463*	21,429
Weighted average shares, diluted thousands of shares	10,732	10,732	10,750	17,080	21,379	21,379	20,310	21,379	21,407	21,463	21,463*	21,429

Balance sheet

CSV

Fiscal quarters (BRLS's year ends in late December)

In thousands of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Cash and cash equivalents	2	70	93	8,211	3,129	722	653	193	207	129	64	500
Accounts receivable	—	—	1,776	4,771	2,545	2,908	1,966	1,779	2,320	2,575	2,648	1,743
Inventory	—	—	6,945	6,803	7,661	8,750	8,046	7,751	7,002	5,998	4,583	3,533
Prepaid and other current assets	—	—	846	—	—	—	1,135	848	402	769	761	1,070
Total current assets	2	83	123	22,183	15,146	13,428	11,800	10,571	9,931	9,471	8,055	6,825
Property and equipment, net	—	—	46,409	45,965	46,064	46,066	45,736	45,272	44,779	44,326	43,892	43,506
Right-of-use asset	—	—	108	98	—	—	64	53	42	31	158	148
Goodwill	—	—	1,917	1,917	1,917	1,917	1,917	1,917	1,917	1,917	—	—
Total assets	21,136	21,611	22,044	70,333	63,595	61,912	60,006	58,398	57,275	56,298	52,573	50,947
Accrued liabilities	2,101	2,697	3,432	—	—	—	—	—	—	—	—	—
Total current liabilities	4,710	6,106	7,487	28,813	28,656	30,299	25,406	35,869	39,424	64,119	69,817	71,847
Total deposits	—	—	21,920	—	—	—	—	—	—	—	—	—
Lease liability, non-current	—	—	71	44	44	44	12	4	—	—	119	111
Total liabilities	—	—	87,134	54,133	53,693	56,842	60,702	63,223	66,445	69,246	71,804	73,649
Accumulated deficit	(4,708)	(6,023)	(7,365)	(73,897)	(80,195)	(85,027)	(90,793)	(94,980)	(99,580)	(103,361)	(109,771)	(113,284)
Total stockholders' equity	(4,707)	(6,023)	(7,365)	16,200	9,902	5,070	(696)	(4,825)	(9,171)	(12,949)	(19,231)	(22,703)
Total liabilities and equity	21,136	21,611	22,044	70,333	63,595	61,912	60,006	58,398	57,275	56,298	52,573	50,947
Common shares outstanding (cover page) thousands of shares	—	—	21,379	21,379	21,379	21,379	21,379	21,382	21,382	21,463	21,463	21,463

Cash flows

CSV

Fiscal quarters (BRLS's year ends in late December)

In thousands of dollars	Q2 FY23Jun 30, 2023	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026
Net income (loss)	(452)	(921)	(838)*	(8,432)	(6,298)	(4,832)	(5,766)*	(4,188)	(4,600)	(3,781)	(6,410)*	(3,512)
Stock-based compensation	98*	100*	100*	1,273	0*	0*	0*	58	255*	3*	—	—
Depreciation and amortization	962	997	999*	994	395	462	462*	481	—	1,408	433*	—
Net cash from operating activities	(692)*	(612)*	(398)*	(6,769)	(4,234)*	(3,267)*	(819)*	(1,373)	(2,197)*	(191)*	(2,839)*	(123)
Purchases of property and equipment	1,933*	662*	950*	551	514*	454*	132*	16	—	—	—	—
Net cash from investing activities	(120)*	(120)*	(107)*	(487)	(724)*	(497)*	(198)*	(26)	(3)*	(33)*	(4)*	—
Proceeds from issuing common stock	0*	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	—	—	year only	—	—	—	—	—	—	—	—	—
Net cash from financing activities	750*	800*	528*	7,852	(124)*	1,356*	949*	938	2,214*	146*	2,778*	539
Net change in cash	—	(3,741)*	(1,355)*	—	—	(2,407)*	(69)*	—	—	—	—	—

Compare with peers

SIC 2000 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2000 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Borealis Foods	500	7,782	(123)	21.5M	4.1 quarters	Q1 FY26 10-QMar 31, 2026
BranchOut Food	0	4,458	(2,788)*	15.3M	—	Q2 FY26 10-QJun 30, 2026
Laird Superfood	22,969	41,294	1,451*	11.2M	—	Q2 FY26 10-QJun 30, 2026
Goldenwell Biotech	11	0	(47)*	99.0M	0.2 quarters	Q2 FY26 10-QJun 30, 2026
Hain Celestial Group	58,078	263,069*	11,443*	91.0M	—	Q4 FY26 10-KJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.